<img src="https://secure.leadforensics.com/133892.png" alt="" style="display:none;">

Columbus welcomes Karina Kirk as new member of the Board of Directors in Columbus.

Copenhagen, 30 April 2018: At the annual general meeting the 24 April 2018, Karina Kirk was elected as new member of Columbus’ Board of Directors. She replaces Deputy Chairman of the Board of Directors Jørgen Cadovius who retires after 12 years of active contribution.

Karina Kirk is 46 years old and educated MSc (Int.) from Copenhagen Business School and has also studied MBA courses at NYU Stern School of Business. She has more than 20 years of experience from the consultancy industry starting in Accenture and later as partner in QVARTZ for eight in leading roles within growth and development as senior strategy advisor for the top management in large Nordic companies. As of 1 May, Karina Kirk joins Matas A/S as Head of Customer Insights, Loyalty and Partners.

”I am pleased to welcome Karina Kirk to Columbus’ Board of Directors. Karina Kirk comes with a strong commercial background with many years of experience with business transformation and customer development in international companies. I look forward to drawing on these skills which I am sure will contribute to the continued growth of Columbus”, says Chairman of the Board, Ib Kunøe.

Columbus board thus consists of:

  • Ib Kunøe, Chairman of the Board
  • Sven Madsen, Deputy Chairman of the Board
  • Peter Skov Hansen, Chairman of the Audit Committee
  • Karina Kirk, Member of the Board

”Columbus is a very exciting company with a leading position within digital transformation. I look forward to working with Ib Kunøe and together with the Board to contribute to the continued development of Columbus”, says Karina Kirk.

Discuss this post

Recommended posts

Minneapolis, Minn. (July 9, 2020): Columbus U.S. has announced a partnership with orthopedic medical device contract manufacturer Mach Medical. Using Microsoft technology, the Columbus U.S. team will help Mach Medical as they revolutionize the orthopedic supply chain by creating a manufacturing organization capable of building the highest quality joint replacement implants from a patient’s pre-operative surgical plan and supplying that product in time for surgery. Mach Medical’s proprietary high velocity, single-piece flow manufacturing approach is designed to reduce OEM implant inventory levels by 80%, trim per-part manufacturing costs by 30%, and cut new product time-to-market by 1-2 years.
Columbus continued the positive development from 2019 with revenue growth in the first two months of the year until COVID-19 hit the world community. Columbus is fully focused on serving customers digitally, adapting the business to the new situation and launching new digital sales and marketing initiatives to increase sales.
2019 was a good year for Columbus with 4% organic growth and EBITDA growth of 39%. The positive development continued in the first two months of the year, after which COVID-19 changed the conditions for 2020. Columbus is fully focused on serving customers and adapting the business to the changing situation.
With an organic growth of 5% in Q3 and EBITDA growth of 48% in Q3 YTD, Columbus delivers a satisfactory result for the first 9 months, thus maintaining the expectations for the year.
With an EBITDA growth of 7%, Columbus delivers a satisfactory first half of 2019, and maintains full year expectations.
right-arrow share search phone phone-filled menu filter envelope envelope-filled close checkmark caret-down arrow-up arrow-right arrow-left arrow-down